96093 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom; Seven-(or more) membered rings condensed with carbocyclic rings or ring systems
NEUTRAL ENDOPEPTIDASE (NEP) AND HUMAN SOLUBLE ENDOPEPTIDASE (HSEP) INHIBITORS TO REDUCE DETRIMENTAL EFFECTS OF PERFUSION DEFICIENCY OF PARENCHYMAL ORGANS
#2APPLICATION OF CLICK CHEMISTRY FOR SIGNAL AMPLIFICATION IN IHC AND ISH ASSAYS
#3BENZAZEPINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#4APPLICATION OF CLICK CHEMISTRY FOR SIGNAL AMPLIFICATION IN IHC AND ISH ASSAYS
#5Application of click chemistry for signal amplification in IHC and ISH assays
#6APPLICATION OF CLICK CHEMISTRY FOR SIGNAL AMPLIFICATION IN IHC AND ISH ASSAYS
#7NEUTRAL ENDOPEPTIDASE (NEP) AND HUMAN SOLUBLE ENDOPEPTIDASE (hSEP) INHIBITORS TO REDUCE DETRIMENTAL EFFECTS OF PERFUSION DEFICIENCY OF PARENCHYMAL ORGANS
#8Application of click chemistry for signal amplification in IHC and ISH assays
#9STAT6 inhibitors
#10COMPOUNDS AND METHODS FOR DETECTION AND ISOLATION OF BIOMOLECULES
#11Cytotoxic agents for conjugation to a cell binding molecule
#12STAT6 inhibitors
#13Benzazepine derivatives useful as vasopressin antagonists
#14Water-soluble benzoazepine compound and its pharmaceutical composition
#15WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION
#16Water-soluble benzoazepine compound and its pharmaceutical composition
#17WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION
#18WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION
#19Benzazepine derivatives useful as vasopressin antagonists
#20WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION
#21Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
#22Substituted phosphonate fluorescent sensors and use thereof
#23Noncardiotoxic pharmaceutical compounds
#24Ansamycins having improved pharmacological and biological properties
#25Ligands for use in catalytic processes